Screener
Ultragenyx Pharmaceutical RARE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's total current assets?
- Ultragenyx Pharmaceutical (RARE) reported total current assets of $606M in Q2 2026.
- How has Ultragenyx Pharmaceutical's total current assets changed year-over-year?
- Ultragenyx Pharmaceutical's total current assets decreased by 15.8% year-over-year, from $719.79M to $606M.
- What is the long-term trend for Ultragenyx Pharmaceutical's total current assets?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's total current assets has grown at a -6.0% compound annual growth rate (CAGR), from $1.3B to $951M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Ultragenyx Pharmaceutical's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude